SNMMI continues advocacy on utility of amyloid imaging

03/27/2013 | MolecularImaging.net

SNMMI and the Alzheimer's Association will meet with CMS officials next month to discuss appropriate use criteria concerning the use of amyloid imaging in evaluating and diagnosing Alzheimer's disease. SNMMI President Frederic H. Fahey said SNMMI "will recommend coverage for the three indications specified by the AUC." Amyloid imaging is not currently reimbursed.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ